Rankings
▼
Calendar
EYPT Q1 2020 Earnings — EyePoint Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$7M
+272.2% YoY
Gross Profit
$7M
86.9% margin
Operating Income
-$11M
-152.8% margin
Net Income
-$13M
-175.9% margin
EPS (Diluted)
$-1.14
QoQ Revenue Growth
-13.3%
Cash Flow
Operating Cash Flow
-$16M
Free Cash Flow
-$16M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$80M
Total Liabilities
$64M
Stockholders' Equity
$16M
Cash & Equivalents
$26M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$7M
$2M
+272.2%
Gross Profit
$7M
$2M
+287.0%
Operating Income
-$11M
-$15M
+21.9%
Net Income
-$13M
-$19M
+31.5%
Revenue Segments
Collaborative Research And Development
$15,000
100%
← FY 2020
All Quarters
Q2 2020 →